BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8506943)

  • 1. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
    Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V
    Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired CD25 expression and soluble CD25-IL-2R alpha receptor release by anti-CD3 stimulated peripheral blood mononuclear cells in Hodgkin's disease patients.
    Frydecka I; Mazur G
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):127-30. PubMed ID: 8915517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
    Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
    Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist.
    Oshima Y; Puri RK
    Cell Immunol; 2001 Jul; 211(1):37-42. PubMed ID: 11585386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.
    Hsu SM; Xie SS; Hsu PL; Waldron JA
    Am J Pathol; 1992 Jul; 141(1):129-38. PubMed ID: 1632458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Martinez RL; Alkan S
    Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-8 in Hodgkin's disease. Preferential expression by reactive cells and association with neutrophil density.
    Foss HD; Herbst H; Gottstein S; Demel G; Araujó I; Stein H
    Am J Pathol; 1996 Apr; 148(4):1229-36. PubMed ID: 8644863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor (VEGF) is expressed by neoplastic Hodgkin-Reed-Sternberg cells in Hodgkin's disease.
    Doussis-Anagnostopoulou IA; Talks KL; Turley H; Debnam P; Tan DC; Mariatos G; Gorgoulis V; Kittas C; Gatter KC
    J Pathol; 2002 Aug; 197(5):677-83. PubMed ID: 12210089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 and tumor necrosis factor-alpha in the Reed-Sternberg cells of Hodgkin's disease. Correlation with clinical and morphological "inflammatory" features.
    Benharroch D; Prinsloo I; Apte RN; Yermiahu T; Geffen DB; Yanai-Inbar I; Gopas J
    Eur Cytokine Netw; 1996; 7(1):51-7. PubMed ID: 8704095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
    Herbst H; Samol J; Foss HD; Raff T; Niedobitek G
    J Pathol; 1997 Jul; 182(3):299-306. PubMed ID: 9349232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 receptor beta and CD57 expression in orbital tissues from patients with chronic, stable thyroid-associated ophthalmopathy.
    Rosen CE; Rizzuto PR; Kennerdell JS; Burde RM; Wall JR
    Alaska Med; 1994; 36(4):177-82, 207. PubMed ID: 7531401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of interleukin-2 and interleukin-4 receptor expression in human and ape lymphoid cell lines.
    Guizani L; Lang P; Stancou R; Bertoglio J
    Lymphokine Cytokine Res; 1993 Feb; 12(1):25-32. PubMed ID: 8457629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?
    Brink AA; Oudejans JJ; van den Brule AJ; Kluin PM; Horstman A; Ossenkoppele GJ; van Heerde P; Jiwa M; Meijer CJ
    Mod Pathol; 1998 Apr; 11(4):376-83. PubMed ID: 9578089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of soluble IL-2 receptor in the serum and bone marrow of patients with minimal residual hematological malignancies: induction under therapy with IL-2.
    Kandefer-Szerszeń M; Legieć W; Dmoszyńska A; Rzeski W
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):443-8. PubMed ID: 9437500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar.
    Serrano D; Ghiotto F; Roncella S; Airoldi I; Cutrona G; Truini M; Burgio VL; Baroni CD; Ferrarini M; Pistoia V
    Haematologica; 1997; 82(5):542-9. PubMed ID: 9407718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
    Rassidakis GZ; Medeiros LJ; McDonnell TJ; Viviani S; Bonfante V; Nadali G; Vassilakopoulos TP; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Clin Cancer Res; 2002 Feb; 8(2):488-93. PubMed ID: 11839668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
    Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of heat shock protein 70 (HSP70) and EBV latent membrane protein 1 (LMP1) in Reed-Sternberg cells of Hodgkin's disease.
    Takahashi H; Fujita S; Shibata Y; Tsuda N; Okabe H
    Anal Cell Pathol; 1996 Nov; 12(2):71-83. PubMed ID: 8986292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abundant expression of transforming growth factor-beta 1 and -beta 2 by Hodgkin's Reed-Sternberg cells and by reactive T lymphocytes in Hodgkin's disease.
    Hsu SM; Lin J; Xie SS; Hsu PL; Rich S
    Hum Pathol; 1993 Mar; 24(3):249-55. PubMed ID: 7681031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.